The link found between MYCN and Oct4 is consistent with Kaneko et al’s [29] results and their model of MYCN/NCYM-Oct4 network in MYCN amplified human NB, which also explains why high Oct4 expression correlated with poor survival rates among patients with MYCN amplification in their analysis. This evidence concerns the gene POU5F1 and neuroblastoma.